3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with ondansetron in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baxter, GS; Blackburn, TP; Kennett, GA; King, FD; Piper, DC; Sanger, GJ; Thomas, DR; Upton, N; Wood, MD | 1 |
1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and ondansetron
Article | Year |
---|---|
BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
Topics: Animals; Anti-Anxiety Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Diazepam; Esophagus; Guinea Pigs; Heart; Ileum; In Vitro Techniques; Indoles; Interpersonal Relations; Ion Channel Gating; Male; Ondansetron; Peripheral Nervous System; Piperazines; Rabbits; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Reflex; Serotonin Antagonists | 1993 |